Erythrocytosis familial, 1
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
14
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Thymic Lymphoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
45
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Protein C measurement
|
phenotype |
|
Laboratory Procedure
|
62
|
522
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Protein C antigen measurement
|
phenotype |
|
Laboratory Procedure
|
62
|
522
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Polycythemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
82
|
22
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Meningitis, Pneumococcal
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
88
|
13
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Rabies (disorder)
|
disease |
Infections
|
Disease or Syndrome
|
123
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Progression of non-small cell lung cancer
|
disease |
|
Neoplastic Process
|
151
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
179
|
70
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lymphoproliferative Disorders
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
14
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Leukemia, T-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
457
|
10
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Mesothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
560
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mood Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
580
|
308
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Developmental delay (disorder)
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
584
|
68
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Head and Neck Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
786
|
118
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |